| Name | (4-NH2)-Exatecan | 
|---|
| Description | (4-NH2)-Exatecan, a topoisomerase inhibitor derivative extracted from patent US20200306243A1, compound A. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. | 
|---|---|
| Related Catalog | |
| References | 
                                 [1]. Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1.  | 
                        
| Molecular Formula | C23H21N3O4 | 
|---|---|
| Molecular Weight | 403.43 |